Email this article 
Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta‑Analysis
Abstract
Metabolic syndrome (MetS) is a predictor of several diseases such as cardiovascular diseases, diabetes, dyslipidemia, stroke, osteoarthritis, certain cancers, and death leading to public health concern in most societies. We aimed to estimate the pooled prevalence and incidence of MetS in Iranian population through a meta‑analysis study. We included cross‑sectional and cohort studies to estimate the overall prevalence and incidence rates of MetS in Iran National databases including MagIran, Science Information Database, IranMedex, and international databases including Medline, Web of Sciences, and Scopus were searched up to October 2017. Finally, 125 studies were included. The total sample size was 472,401 with a mean age of 38 ± 7.8 years. The overall pooled prevalence and incidence rate among the general population of Iran was 0.26 (95% CI: 0.26, 0.29)
and 97.96 (95% CI: 75.98, 131.48), respectively. The pooled prevalence of MetS was higher in females and in urban areas. The highest and lowest prevalence of MetS was obtained by the Iranian definition criteria (0.43) and the NHANES III (0.12). The highest and lowest incidence rates of MetS were obtained by IDF (144.07 per 1000) and the JIS (89.73 per 1000). The prevalence of MetS was
higher in women and those living in urban areas. Furthermore, the prevalence of MetS increased with increasing age in both genders.
Keywords: Incidence, Iran, meta‑analysis, metabolic syndrome, prevalence, review
Full Text:
PDFReferences
Alberti K, Zimmet P, Shaw J. Metabolic syndrome—A
new world‑wide definition. A consensus statement from the
International Diabetes Federation. Diabetic Med 2006;23:469‑80.
Ford ES. Risks for all‑cause mortality, cardiovascular disease,
and diabetes associated with the metabolic syndrome: A summary
of the evidence. Diabetes Care 2005;28:1769‑78.
Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS,
Haffner SM, et al. Metabolic syndrome with and without
C‑reactive protein as a predictor of coronary heart disease and
diabetes in the West of Scotland Coronary Prevention Study.
Circulation 2003;108:414‑9.
Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S,
Marini F, et al. The metabolic syndrome is an independent
predictor of cardiovascular disease in type 2 diabetic subjects.
Prospective data from the verona diabetes complications study.
Diabetic Medi 2004;21:52‑8.
Williams MA, Haskell WL, Ades PA, Amsterdam EA, Bittner V,
Franklin BA, et al. Resistance exercise in individuals with
and without cardiovascular disease: 2007 update: A scientific
statement from the American Heart Association council on
clinical cardiology and council on nutrition, physical activity,
and metabolism. Circulation 2007;116:572‑84.
Schlenk EA, Erlen JA, Dunbar‑Jacob J, McDowell J, Engberg S,
Sereika SM, et al. Health‑related quality of life in chronic
disorders: A comparison across studies using the MOS SF‑36.
Qual Life Res 1997;7:57‑65.
Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic
syndrome and antioxidant concentrations findings from the
third national health and nutrition examination survey. Diabetes
;52:2346‑52.
Ghotbodin MS, Mirmiran P, Bahadoran Z, Mehrabi Y, Azizi F.
The association between dairy intake with metabolic syndrome
and its components in adolescents: Tehran Lipid and Glucose
Study. IJEM 2014;16:270‑82.
Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and
insulin resistance: Perioperative considerations. Anesthesiology
;108:506‑23.
Kazemi S, Koosha A, Sharifi F, Moosavi‑Nasab S, Mellati A.
Metabolic syndrome prevalence in 17‑21 years old population
of Zanjan: A new definition for waist circumference in Iranians
in comparison with ATPIII and World Diabetes Association. Iran
Diabetes Lipid J 2008;7:393‑8.
Jalalzadeh M, Mohammadi R, Mirzamohammadi F,
Ghadiani MH. Prevalence of metabolic syndrome in a
hemodialysis population. Iran J Kidney Dis 2011;5:248‑54.
Khezeli M. Study on the prevalence of hypertension and
its associated factors in the elderly population. Rev Prat
;62:1225‑8.
Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F,
Tohidi M. Incidence of metabolic syndrome over 9 years
follow‑up; the importance of sex differences in the role
of insulin resistance and other risk factors. PloS one
;8:e76304.
Haghparast F, Norooz‑Zadeh J. Metabolic syndrome prevalence
in urban adult population of the south of Iran. Iranian Nutrition
Congress. Tabriz; 2006.
Maleki F, Sayehmiri F, Kiani F, Nasiri S. Metabolic syndrome
prevalence in Iran: A systematic review and meta‑analysis.
J Kermanshah Univ Med Sci 2014;18:242‑50.
Dalvand S, Niksima SH, Meshkani R, Gheshlagh RG,
Sadegh‑Nejadi S, Kooti W, et al. Prevalence of metabolic
syndrome among iranian population: A systematic review and
meta‑analysis. Iran J Public Health 2017;46:456‑67.
Knottnerus A, Tugwell P. STROBE–A checklist to strengthen
the reporting of observational studies in epidemiology. J Clin
Epidemiol 2008;61:323.
Afarideh M, Behdadnia A, Noshad S, Mirmiranpour H,
Mousavizadeh M, Khajeh E, et al. Association of peripheral
‑hydroxyindole‑3‑acetic acid, a serotonin derivative, with metabolic syndrome and low‑grade inflammation. Endocr Pract
;21:711‑8.
Afkhami‑Ardekani M, Zahedi‑Asl S, Rashidi M, Atifah M,
Hosseinpanah F, Azizi F. Incidence and trend of a metabolic
syndrome phenotype among Tehranian adolescents: Findings
from the Tehran Lipid and Glucose Study, 1998‑2001 to
‑2006. Diabetes Care 2010;33:2110‑2.
Afrand M, Khalilzadeh SH, Shojaoddiny‑Ardekani A,
Afkhami‑Ardekani M, Ariaeinejad A. High frequency of
metabolic syndrome in adult Zoroastrians in Yazd, Iran:
A cross‑sectional study. Med J Islam Repub Iran 2016;30:370.
Ahmadi A, Gharipour M, Nouri F, Kelishadi R, Sadeghi M,
Sarrafzadegan N. Association between adolescence obesity and
metabolic syndrome: Evidence from Isfahan Healthy Heart
Program. Indian J Endocrinol Metab 2014;18:569‑73.
Ainy E, Mirmiran P, Asl SZ, Azizi F. Prevalence of metabolic
syndrome during menopausal transition Tehranian women: Tehran
Lipid and Glucose Study (TLGS). Maturitas 2007;58:150‑5.
Alavi SS, Makarem J, Mehrdad R, Abbasi M. Metabolic
syndrome: A common problem among office workers. Int J
Occup Environ Med 2015;6:34‑40.
Amiri A, Hakimi A. The study of prevalence of metabolic
syndrome among nurses of Shahid Mohammadi Hospital of
Bandar Abbas city, Iran. J Clin Nurs Midwifery 2017;6:1‑8.
Ansari R, Kahbazi M, Abdar EM. Determining the prevalence of
metabolic syndrome phenotypes among heypertensive patients in
Isfahan and Markazi provinces in Iran 2007.
Asghari G, Yuzbashian E, Mirmiran P, Mahmoodi B, Azizi F.
Fast food intake increases the incidence of metabolic syndrome
in children and adolescents: Tehran Lipid and Glucose Study.
PLoS One 2015;10:e0139641.
Azimi‑Nezhad M, Herbeth B, Siest G, Dadé S, Ndiaye NC,
Esmaily H, et al. High prevalence of metabolic syndrome in
Iran in comparison with France: What are the components that
explain this? Metab Syndr Relat Disord 2012;10:181‑8.
Azizi F, Mirmiran P, Momenan AA, Hadaegh F, Habibi Moeini A,
Hosseini F, et al. The effect of community‑based education for
lifestyle intervention on the prevalence of metabolic syndrome
and its components: Tehran Lipid and Glucose Study. Int J
Endocrinol Metabol 2013;11:145‑53.
Azizi F, Salehi P, Etemadi A, Zahedi‑Asl S. Prevalence of
metabolic syndrome in an urban population: Tehran Lipid and
Glucose Study. Diabetes Res Clin Pract 2003;61:29‑37.
Bagherniya M, Khayyatzadeh S, Avan A, Safarian M, Nematy M,
Ferns G, et al. Metabolic syndrome and its components are
related to psychological disorders: A population based study.
Diabetes Metab Syndr 2017;11:S561‑6.
Bahrani R, Chan YM, Khor GL, Rahman HA, Esmailzadeh A,
Wong TW. The relationship between metabolic syndrome and its
components with socio‑economic status among adolescents in
Shiraz, Southern Iran. Southeast Asian J Trop Med Public Health
;47:263‑76.
Barzin M, Asghari G, Hosseinpanah F, Mirmiran P, Azizi F.
The association of anthropometric indices in adolescence with
the occurrence of the metabolic syndrome in early adulthood:
Tehran Lipid and Glucose Study (TLGS). Pediatr Obes
;8:170‑7.
Barzin M, Hosseinpanah F, Fekri S, Azizi F. Predictive value
of body mass index and waist circumference for metabolic
syndrome in 6‑12‑year‑olds. Acta paediatrica (Oslo, Norway:
2011;100:722‑7.
Barzin M, Hosseinpanah F, Saber H, Sarbakhsh P, Nakhoda K,
Azizi F. Gender differences time trends for metabolic syndrome
and its components among tehranian children and adolescents.
Cholesterol 2012;2012:804643.
Bayani MA, Yazdani E, Karkhah A, Moodi S, Bijani A,
Hosseini SR. Prevalence of metabolic syndrome and its
components in the Iranian elderly people: Results from AHAP
study. Int J Adv Biotechnol Res 2016;7:2235‑42.
Chiti H, Hosseinpanah F, Mehrabi Y, Azizi F. The prevalence
of metabolic syndrome in adolescents with varying degrees of
body weight: Tehran Lipid and Glucose Study (TLGS). Iran J
Endocrinology Metab 2010;11:625‑37.
Chiti H, Shakibi E, Soltani Z, Mazloomzadeh S, Mousavinasab S.
Prevalence of metabolic syndrome and cardiovascular risk factors
among physicians of Zanjan City. ZUMS J 2016;24:10‑20.
Deihim T, Amiri P, Taherian R, Tohidi M, Ghasemi A,
Cheraghi L, et al. Which insulin resistance‑based definition of
metabolic syndrome has superior diagnostic value in detection of
poor health‑related quality of life? Cross‑sectional findings from
Tehran Lipid and Glucose Study. Health Qual Life Outcomes
;13:194.
Delavar MA, Lye MS, Khor GL, Hanachi P, Hassan S.
Prevalence of metabolic syndrome among middle aged women
in babol, Iran. Southeast Asian J Trop Med Public Health
;40:612‑28.
Delvarianzadeh M, Abbasian M, Khosravi F, Ebrahimi H,
Ebrahimi MH, Fazli M. Appropriate anthropometric indices of
obesity and overweight for diagnosis of metabolic syndrome
and its relationship with oxidative stress. Diabetes Metab Syndr
;11(Suppl 2):S907‑S11.
Ebrahimi H, Emamian MH, Shariati M, Hashemi H, Fotouhi A.
Metabolic syndrome and its risk factors among middle aged
population of Iran, a population based study. Diabetes Metab
Syndr 2016;10:19‑22.
Ebrahimi MH, Delvarianzadeh M, Saadat S. Prevalence of
metabolic syndrome among Iranian occupational drivers.
Diabetes Metab Syndr 2016;10 (1 Suppl 1):S46‑51.
Ebrahimpour P, Fakhrzadeh H, Heshmat R, Bandarian F,
Larijani B. Serum uric acid levels and risk of metabolic
syndrome in healthy adults. Endocr Pract 2008;14:298‑304.
Ebrahimpour P, Fakhrzadeh H, Heshmat R, Ghodsi M,
Bandarian F, Larijani B. Metabolic syndrome and menopause:
A population‑based study. Diabetes Metab Syndr 2010;4:5‑9.
Ejtahed HS, Bahadoran Z, Mirmiran P, Azizi F. Sugar‑sweetened
beverage consumption is associated with metabolic syndrome
in Iranian adults: Tehran Lipid and Glucose Study. Endocrinol
Metab (Seoul, Korea) 2015;30:334‑42.
Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an
independent predictor of metabolic syndrome in Iranian women.
Maturitas 2010;65:262‑6.
Eslamian G, Mirmiran P, Asghari G, Hosseini‑Esfahani F,
Yuzbashian E, Azizi F. Low carbohydrate diet score does not
predict metabolic syndrome in children and adolescents: Tehran
Lipid and Glucose Study. Arch Iran Med 2014;17:417‑22.
Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A,
Azizi F. High prevalence of the metabolic syndrome in Iranian
adolescents. Obesity (Silver Spring, Md) 2006;14:377‑82.
Esmailnasab N, Moradi G, Delaveri A. Risk factors of
non‑communicable diseases and metabolic syndrome. Iran J
Public Health 2012;41:77‑85.
Esmailzadehha N, Ziaee A, Kazemifar A, Ghorbani A, Oveisi S.
Prevalence of metabolic syndrome in Qazvin Metabolic Diseases
Study (QMDS), Iran: A comparative analysis of six definitions.
Endocr Regul 2013;47:111‑20.
Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut‑off points for the diagnosis of metabolic
syndrome in Iranian adults. Diabetes Res Clin Pract
;82:104‑7.
Esteghamati A, Khalilzadeh O, Anvari M, Ahadi MS, Abbasi M,
Rashidi A. Metabolic syndrome and insulin resistance
significantly correlate with body mass index. Arch Med Res
;39:803‑8.
Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, Heshmat R,
Larijani B. Homocysteine levels and its correlation to metabolic
syndrome in 25‑64 years old residents of the Tehran Medical
University Population Lab. Iranian J of Diabetes and Metabolism
;4:71‑8. [in Persian].
Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, Heshmat R,
Larijani B. Metabolic syndrome and its associated risk factors in
healthy adults: A population‑based study in Iran. Metab Syndr
Relat Disord 2006;4:28‑34.
Frootan M, Mahdavi R, Moradi T, Mobasseri M, Farrin N.
Prevalence of metabolic syndrome in an elderly population of
Tabriz, Iran. Endocrinol Metabol Syndrome S 2011;1:S1:003.
Gharipour M, Baghaie AM, Boshtam M, Rabeie K. Prevalence
of metabolic syndrome in an Iranian adult population. ARYA
Atherosclerosis 2010;1:188‑92.
GhariPour M, Baghei A, Boshtam M, Rabiei K. Prevalence of
metabolic syndrome among the adults of central of areas of
Iran (as part of” Isfahan Healthy Heart Study”). J Birjand Univ
Med Sci 2006;13:9‑15.
Ghasemi A, Zahediasl S, Azizi F. Nitric oxide and clustering of
metabolic syndrome components in pediatrics. Eur J Epidemiol
;25:45‑53.
Ghasemi A, Zahediasl S, Azizi F. High serum nitric oxide
metabolites and incident metabolic syndrome. Scand J Clin Lab
Invest 2012;72:523‑30.
Ghorbani R, Abtahi Naeini B, Eskandarian R, Rashidy‑Pour A,
Khamseh ME, Malek M. Prevalence of metabolic syndrome
according to ATPIII and IDF criteria in the Iranian population.
Koomesh 2012;14:65‑75.
Ghotboddin Mohammadi S, Mirmiran P, Bahadoran Z, Mehrabi Y,
Azizi F. The association of dairy intake with metabolic syndrome
and its components in adolescents: Tehran Lipid and Glucose
Study. Int J Endocrinol Metab 2015;13:e25201.
Hadaegh F, Zabetian A, Azizi F. Prevalence of metabolic
syndrome in Iranian adult population, concordance between the
IDF with the ATPIII and the WHO definitions. Iran J Diabetes
Lipid Disord 2007;6:59‑67+E44.
Hajian‑Tilaki K, Heidari B, Firouzjahi A, Bagherzadeh M,
Hajian‑Tilaki A, Halalkhor S. Prevalence of metabolic syndrome
and the association with socio‑demographic characteristics
and physical activity in urban population of Iranian adults:
A population‑based study. Diabetes Metab Syndr 2014;8:170‑6.
Heidari R, Sadeghi M, Talaei M, Rabiei K, Mohammadifard N,
Sarrafzadegan N. Metabolic syndrome in menopausal transition:
Isfahan Healthy Heart Program, a population based study.
Diabetol Metab Syndr 2010;2:59.
Heidari Z, Hosseinpanah F, Mehrabi Y, Safarkhani M, Azizi F.
Predictive power of the components of metabolic syndrome in
its development: A 6.5‑year follow‑up in the Tehran Lipid and
Glucose Study (TLGS). Eur J Clin Nutr 2010;64:1207‑14.
Hosseini M, Sarrafzadegan N, Kelishadi R, Monajemi M,
Asgary S, Vardanjani HM. Population‑based metabolic syndrome
risk score and its determinants: The Isfahan Healthy Heart
Program. J Res Med Sci 2014;19:1167‑74.
Hosseini N, Talaei M, Dianatkhah M, Sadeghi M, Oveisgharan S,
Sarrafzadegan N. Determinants of incident metabolic syndrome
in a middle eastern population: Isfahan Cohort Study. Metab
Syndr Relat Disord 2017;15:354‑62.
Hossein‑Nezhad A, Nikoo MK, Maghbooli Z, Karimi F,
Mirzaei K, Hosseini A, et al. Relationship between serum
Vitamin D concentration and metabolic syndrome among Iranian
adults population. Daru 2009;17:1‑5.
Hosseinpanah F, Asghari G, Barzin M, Ghareh S, Azizi F.
Adolescence metabolic syndrome or adiposity and early adult
metabolic syndrome. J Pediatr 2013;163:1663‑9.e1.
Hosseinpanah F, Barzin M, Mirmiran P, Azizi F. Effect of
changes in waist circumference on metabolic syndrome over a
6‑year follow‑up in Tehran. Eur J Clin Nutr 2010;64:879‑86.
Hosseinpanah F, Borzooei S, Barzin M, Farshadi M, Sarvghadi F,
Azizi F. Diagnostic values of metabolic syndrome definitions
for detection of insulin resistance: Tehran Lipid and Glucose
Study (TLGS). Arch Iran Med 2012;15:606‑10.
Hosseinpanah F, Salehpour M, Asghari G, Barzin M, Mirmiran P,
Hatami H, et al. Adolescent metabolic phenotypes and early
adult metabolic syndrome: Tehran lipid and glucose study.
Diabetes Res Clin Pract 2015;109:287‑92.
Hosseinpour‑Niazi S, Hosseini S, Mirmiran P, Azizi F.
Prospective study of nut consumption and incidence of metabolic
syndrome: Tehran Lipid and Glucose Study. Nutrients 2017;9.
doi: 10.3390/nu9101056.
Hosseinpour‑Niazi S, Mirmiran P, Mirzaei S, Azizi F. Cereal,
fruit and vegetable fibre intake and the risk of the metabolic
syndrome: A prospective study in the Tehran Lipid and Glucose
Study. J Hum Nutr Diet 2015;28:236‑45.
Jalali R, Vasheghani M, Dabbaghmanesh MH, Ranjbar
Omrani G. Prevalence of metabolic syndrome among adults in a
rural area. Iran J Endocrinology Metab 2009;11:405‑14+77.
Jalilolghadr S, Javadi A, Mahram M, Farshidgohar M, Javadi M.
Prevalence of metabolic syndrome and insulin resistance in
children and adolescent of Qazvin, Iran. Malays J Med Sci
;22:32‑9.
Janghorbani M, Amini M. Glycated hemoglobin as a predictor
for metabolic syndrome in an Iranian population with normal
glucose tolerance. Metab Syndr Relat Disord 2012;10:430‑6.
Janghorbani M, Amini M. Low‑density lipoprotein cholesterol
and metabolic syndrome in an Iranian high‑risk population.
Diabetes Metab Syndr 2015;9:91‑7.
Jouyandeh Z, Nayebzadeh F, Qorbani M, Asadi M. Metabolic
syndrome and menopause. J Diabetes Metab Disord 2013;12:1.
Karandish M, Hosseinpour M, Rashidi H, Latifi SM, Aleali AM.
Prevalence of metabolic syndrome in normal weight children and
adolescents in Ahvaz, Iran. J Am Coll Cardiol 2016;68:C69‑C.
Karimi F, Jahandideh D, Dabbaghmanesh M, Fattahi M,
Omrani GR. The prevalence of metabolic syndrome and its
components among adults in a rural community, Fars, Iran. Int
Cardiovasc Res J 2015;9:94‑9.
Kaykhaei M, Hashemi M, Narouie B, Shikhzadeh A,
Jahantigh M, Shirzaei E, et al. Prevalence of metabolic syndrome
in adult population from Zahedan, Southeast Iran. Iran J Public
Health 2012;41:70‑6.
Kelishadi R, Ardalan G, Adeli K, Motaghian M, Majdzadeh R,
Mahmood‑Arabi MS, et al. Factor analysis of cardiovascular risk
clustering in pediatric metabolic syndrome: CASPIAN study.
Ann Nutr Metab 2007;51:208‑15.
Khosravi‑Boroujeni H, Ahmed F, Sadeghi M, Roohafza H,
Talaei M, Dianatkhah M, et al. Does the impact of metabolic
syndrome on cardiovascular events vary by using different
definitions? BMC Public Health 2015;15:1313.
Khosravi‑Boroujeni H, Sarrafzadegan N, Sadeghi M, Roohafza H, Talaei M, Ng SK, et al. Secular trend of metabolic
syndrome and its components in a cohort of Iranian adults from
to 2013. Metab Syndr Relat Disord 2017;15:137‑44.
Maharlouei N, Bellissimo N, Ahmadi SM, Lankarani KB.
Prevalence of metabolic syndrome in pre‑ and postmenopausal
Iranian women. Climacteric 2013;16:561‑7.
Mahjoub S, Ahmadi MH, Faramarzi M, Ghorbani H, Moazezi Z.
The prevalence of metabolic syndrome according to the Iranian
Committee of Obesity and ATP III criteria in Babol, North of
Iran. Caspian J Int Med 2012;3:410‑6.
Maleki R, Mostafazadeh M, Nazari Sharif H, Rahim Nejad S,
Gorgani‑Firuzjaee S. The prevalence of metabolic syndrome
in Air Guard Forces of Iran Army. Paramed Sci Mil Health
;11:8‑16.
Marjani A, Hezarkhani S, Shahini N. Prevalence of metabolic
syndrome among fars ethnic women in North East of Iran. World
J Med Sci 2012;7:17‑22.
Marjani A, Moghasemi S. The metabolic syndrome among
postmenopausal women in Gorgan. Int J Endocrinol
;2012:953627.
Mehrdad M, Hosseinpanah F, Azizi F. Prevalence of metabolic
syndrome among 3‑9 years old children inTehran Lipid and
Glucose Study. Res Med 2006;30:337‑47.
Mehrkash M, Mohammadian S, Qorbani M, Eshghinia S,
Shafa N. Prevalency of metabolic syndrome among adolescents
aged 15 to 17 years in Gorgan, Northern Iran (2009). J Gorgan
Univ Med Sci 2011;13.
Mirhosseini NZ, Yusoff NA, Shahar S, Parizadeh SM,
Mobarhen MG, Shakery MT. Prevalence of the metabolic
syndrome and its influencing factors among adolescent girls in
Mashhad, Iran. Asia Pac J Clin Nutr 2009;18:131‑6.
Mirmiran P, Noori N, Azizi F. A prospective study of
determinants of the metabolic syndrome in adults. Nutr Metab
Cardiovasc Dis 2008;18:567‑73.
Mirmiran P, Sherafat‑Kazemzadeh R, Farahani SJ, Asghari G,
Niroomand M, Momenan A, et al. Performance of different
definitions of metabolic syndrome for children and adolescents
in a 6‑year follow‑up: Tehran Lipid and Glucose Study (TLGS).
Diabetes Res Clin Pract 2010;89:327‑33.
Mirmiran P, Yuzbashian E, Asghari G, Hosseinpour‑Niazi S,
Azizi F. Consumption of sugar sweetened beverage is associated
with incidence of metabolic syndrome in Tehranian children and
adolescents. Nutr Metab 2015;12:25.
Mohammadbeigi R, Fatholapour A, Khodaverdi S, Delpisheh A,
Khodaverdi M, Afkhamzadeh A. Epidemiology of metabolic
syndrome among women of reproductive age in Abhar City in
Western Iran. Pak J Med Sci 2011;27:1116‑20.
Mohebbi I, Saadat S, Aghassi M, Shekari M, Matinkhah M,
Sehat S. Prevalence of metabolic syndrome in Iranian
professional drivers: Results from a population based study of
,138 men. PLoS One 2012;7:e31790.
Moradi S, Zamani F, Pishgar F, Ordookhani S, Nateghi N,
Salehi F. Parity, duration of lactation and prevalence of maternal
metabolic syndrome: A cross‑sectional study. Eur J Obstet
Gynecol Reprod Biol 2016;201:70‑4.
Motamed N, Razmjou S, Hemmasi G, Maadi M, Zamani F.
Lipid accumulation product and metabolic syndrome:
A population‑based study in northern Iran, Amol. J Endocrinol
Invest 2016;39:375‑82.
Mousavi A, Biglari A, Reyhanian M. Prevalence of metabolic
syndrome and its related criteria in health network personnel in
Babolsar, 2012. J Mazandaran Univ Med Sci 2015;24:379‑83.
Mousavi E, Gharipour M, Tavassoli A, Sadri GH,
Sarrafzadegan N. Multiparity and risk of metabolic syndrome:
Isfahan Healthy Heart Program. Metab Syndr Relat Disord
;7:519‑24.
Nabipour I, Amiri M, Imami SR, Jahfari SM, Shafeiae E,
Nosrati A, et al. The metabolic syndrome and nonfatal
ischemic heart disease; a population‑based study. Int J Cardiol
;118:48‑53.
Najafian J, Toghianifar N, Mohammadifard N, Nouri F.
Association between sleep duration and metabolic syndrome in
a population‑based study: Isfahan Healthy Heart Program. J Res
Med Sci 2011;16:801‑6.
Ostovaneh MR, Zamani F, Sharafkhah M, Ansari‑Moghaddam A,
Akhavan Khaleghi N, Saeedian FS, et al. Prevalence of
metabolic syndrome in Amol and Zahedan, Iran: A population
based study. Arch Iranian Med 2014;17:477‑82.
Pasdar Y, Nazari LH, Rezaei M, Barzegar A, Darbandi M,
Niazi P. Which factors predict metabolic syndrome? A cross
sectional study in Kermanshah, Iran. Ann Trop Med Public
Health 2017;10:993‑8.
Payab M, Hasani‑Ranjbar S, Merati Y, Esteghamati A,
Qorbani M, Hematabadi M, et al. The prevalence of metabolic
syndrome and different obesity phenotype in Iranian male
military personnel. Am J Mens Health 2017;11:404‑13.
Rafraf M, Hasanabad SK, Jafarabadi MA. Vitamin D status
and its relationship with metabolic syndrome risk factors
among adolescent girls in Boukan, Iran. Public Health Nutr
;17:803‑9.
Rahmanian K, Shojaie M. Prevalence of metabolic syndrome in
an adult urban population in the South of Iran. Iran J Diabetes
Obesity 2011;3:77‑82.
Rashidi AA, Parastouei K, Aarabi MH, Taghadosi M,
Khandan A. Prevalence of metabolic syndrome among students
of Kashan University of Medical Sciences in 2008. KAUMS
J (FEYZ) 2010;13:307‑12.
Rashidi H, Payami SP, Latifi SM, Karandish M, Moravej Aleali A,
Aminzadeh M, et al. Prevalence of metabolic syndrome and its
correlated factors among children and adolescents of Ahvaz aged
‑19. J Diabetes Metab Disord 2014;13:53.
Rezaei Kheirabadi M, Asghari G, Mirmiran P, Mehrabi Y,
Azizi F. Comparison of body fat percentage with anthropometric
indices for identification of metabolic syndrome in Tehranian
adolescents. J Babol Univ Med Sci 2014;16:25‑34.
Saberi HR, Moravveji AR, Fakharian E, Kashani MM,
Dehdashti AR. Prevalence of metabolic syndrome in bus and
truck drivers in Kashan, Iran. Diabetol Metab Syndr 2011;3:8.
Sadeghi M, Roohafza H, Shirani S, Baghaei A, Golshadi I,
Aghdak P. Relationship between hematological factors and
metabolic syndrome in an Iranian Population Isfahan Healthy
Heart Program. J Rafsanjan Univ Med Sci 2006;5:109‑16.
Sadrbafoghi S, Salari M, Rafiee M, Namayandeh S, Abdoli A,
Karimi M. Prevalence and criteria of metabolic syndrome in an
urban population: Yazd Healthy Heart Project. Tehran Univ Med
J 2006;64:90‑6.
Salem Z, Vazirinejad R. Prevalence of obesity and metabolic
syndrome in adolescent girls in South East of Iran. Pak J Med
Sci 2009;25:196‑200.
Sanjari M, Khodashahi M, Gholamhoseinian A, Shokoohi M.
Association of adiponectin and metabolic syndrome in women.
J Res Med Sci 2011;16:1532‑40.
Saraei M, Heidarbagi E, Najafi A. Prevalence of metabolic
syndrome and risk factors of obstructive sleep apnea among
locomotive drivers. J Sleep Res 2016;25:347.
Sarebanhassanabadi M, Mirhosseini SJ, Mirzaei M, Namayandeh SM, Soltani MH, Pedarzadeh A, et al. The
incidence of metabolic syndrome and the most powerful
components as predictors of metabolic syndrome in central Iran:
A 10‑year follow‑up in a cohort study. Iran Red Crescent Med J
;19:10.
Sarrafzadegan N, Gharipour M, Ramezani MA, Rabiei K,
Zolfaghar B, Tavassoli AA, et al. Metabolic syndrome and
health‑related quality of life in Iranian population. J Res Med Sci
;16:254‑61.
Sarrafzadegan N, Kelishadi R, Baghaei A, Hussein Sadri G,
Malekafzali H, Mohammadifard N, et al. Metabolic syndrome:
An emerging public health problem in Iranian women: Isfahan
healthy heart program. Int J Cardiol 2008;131:90‑6.
Schwandt P, Kelishadi R, Haas GM. Ethnic disparities of the
metabolic syndrome in population‑based samples of German and
Iranian adolescents. Metab Syndr Relat Disord 2010;8:189‑92.
Schwandt P, Kelishadi R, Ribeiro RQ, Haas GM, Poursafa P.
A three‑country study on the components of the metabolic
syndrome in youths: The BIG study. Int J Pediatr Obes
;5:334‑41.
Sh GM, Mirmiran P, Bahadoran Z, Mehrabi Y, Azizi F. The
association between dairy intake with metabolic syndrome and
its components in adolescents: Tehran lipid and glucose study.
Iran J Endocrinol Metab 2014;16:270‑82.
Shahbazian H, Latifi SM, Jalali MT, Shahbazian H, Amani R,
Nikhoo A, et al. Metabolic syndrome and its correlated factors
in an urban population in South West of Iran. J Diabetes Metab
Disord 2013;12:11.
Shahini N, Shahini I, Marjani A. Prevalence of metabolic
syndrome in turkmen ethnic groups in gorgan. J Clin Diagn Res
;7:1849‑51.
Sharifi F, Mousavinasab SN, Saeini M, Dinmohammadi M.
Prevalence of metabolic syndrome in an adult urban population
of the west of Iran. Exp Diabetes Res 2009;2009:136501.
Shirani F, Esmaillzadeh A, Keshteli AH, Adibi P, Azadbakht L.
Low‑carbohydrate‑diet score and metabolic syndrome:
An epidemiologic study among Iranian women. Nutrition
;31:1124‑30.
Soltani Z, Khamse M, Chiti H, Valizadeh M, Mazloomzadeh S.
Plasma 25 (OH) vitamin‑D level and metabolic syndrome risk
factors among physicians of Zanjan. J Zanjan Univ Med Sci
Health Serv 2015;23:64‑73.
Sourinejad H, Moghaddam BL, Niyati S. The metabolic
syndrome and its components in mid‑pregnancy in Tehran,
‑14. J Urmia Nurs Midwifery Fac 2016;14:465‑73.
Tabari MG, Naseri F, Paad E, Majidi F, Marjani A. Prevalence
of metabolic syndrome in baluch women in Chabahar. Int J
Osteoporosis Metab Disord 2015;8:27‑34.
Tabatabaie AH, Shafiekhani M, Nasihatkon AA, Rastani IH,
Tabatabaie M, Borzoo AR, et al. Prevalence of metabolic
syndrome in adult population in Shiraz, Southern Iran. Diabetes
Metab Syndr 2015;9:153‑6.
Veghari G, Sedaghat M, Banihashem S, Moharloei P, Angizeh A,
Tazik E, et al. The prevalence of metabolic syndrome in the
north of Iran. An epidemiologic comparative study. J Cardiovasc
Dis Res 2015;6:172‑5.
Yousefzadeh G, Sheikhvatan M. Age and gender differences
in the clustering of metabolic syndrome combinations:
A prospective cohort research from the Kerman Coronary Artery
Disease Risk Study (KERCADRS). Diabetes Metab Syndr
;9:337‑42.
Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic
syndrome in Iranian adult population, concordance between the
IDF with the ATPIII and the WHO definitions. Diabetes Res Clin
Pract 2007;77:251‑7.
Zabetian A, Hadaegh F, Sarbakhsh P, Azizi F. Weight change
and incident metabolic syndrome in Iranian men and women; a
year follow‑up study. BMC Public Health 2009;9:138.
Zabetian A, Hadaegh F, Tohidi M, Sheikholeslami F, Azizi F.
Prevalence of metabolic syndrome by the ATPIII, IDF and WHO
definitions and their association to coronary heart disease in
Iranian elderly population. Iran J Diabetes Metab 2007;7:91‑101.
Zardast M, Namakin K, Chahkandi T, Taheri F, Kazemi T,
Bijari B. Prevalence of metabolic syndrome in elementary
school children in East of Iran. J Cardiovasc Thorac Res
;7:158‑63.
Zaribaf F, Falahi E, Barak F, Heidari M, Keshteli AH,
Yazdannik A, et al. Fish consumption is inversely associated
with the metabolic syndrome. Eur J Clin Nutr 2014;68:474‑80.
Ziaee A, Esmailzadehha N, Ghorbani A, Asefzadeh S.
Association between uric acid and metabolic syndrome in qazvin
metabolic diseases study (QMDS), Iran. Glob J Health Sci
;5:155‑65.
Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of
the metabolic syndrome in the United States, 2003‑2012. Jama
;313:1973‑4.
Bhupathiraju SN, Stampfer MJ. Menopausal hormone therapy
and cardiovascular disease: Unraveling the role of age and time
since menopause onset. Clin Chem 2018;64:861‑2.
Galassi A, Reynolds K, He J. Metabolic syndrome and risk of
cardiovascular disease: A meta‑analysis. Am J Med 2006;119:812‑9.
Sayehmiri F. Metabolic syndrome prevalence in
Iran: A systematic review and meta‑analysis. J Kermanshah Univ
Med 2014;18:242‑50. [in Persian].
Abdul‑Rahim HF, Husseini A, Bjertness E, Giacaman R,
Gordon NH, Jervell J. The metabolic syndrome in the West
Bank population: An urban‑rural comparison. Diabetes Care
;24:275‑9.